FDA official logo
GSRS logo
PFDA official logo

TEPROTUMUMAB

  • UNII: Y64GQ0KC0A
  • Preferred Substance Name: TEPROTUMUMAB

  • 1036734-93-6
  • 289-554-4
  • HZN001
  • HZN-001
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (CD221)), HUMAN MONOCLONAL IMC-11F8 .GAMMA.1 HEAVY CHAIN (221-215')-DISULFIDE WITH HUMAN MONOCLONAL IMC-11F8 .KAPPA. LIGHT, DIMER (227-227'':230-230'')-BISDISULFIDE
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN INSULIN-LIKE GROWTH FACTOR I RECEPTOR) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
  • R-1507
  • RG1507
  • RG-1507
  • RO4858696
  • RO-4858696
  • RO4858696-000
  • RO-4858696000
  • RO-4858696-000
  • RV001 MONOCLONAL
  • RV-001 MONOCLONAL
  • TEPEZZA
  • TEPROTUMUMAB [INN]
  • TEPROTUMUMAB [MI]
  • TEPROTUMUMAB [USAN]
  • TEPROTUMUMAB [WHO-DD]
  • TEPROTUMUMAB TRBW [WHO-DD]
  • TEPROTUMUMAB-TRBW

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.